Short-Read Sequencing

Illumina’s sequencing-by-synthesis technology is the global standard for short-read sequencing. At CRID, we operate both the NovaSeq 6000 and MiSeq platforms, offering scalable solutions for projects of all sizes.

Short-read sequencing is ideal for applications such as:

Infectious disease research
Cancer genomics
Agrigenomics
Environmental studies
Human and microbial transcriptomics
Food safety and metagenomics
Animal and plant microbiome studies

1. NovaSeq 6000

High-throughput sequencing for large-scale projects

The NovaSeq 6000 delivers exceptional speed, scalability, and cost-efficiency for high-volume sequencing. It supports a wide range of applications, including:

Whole-genome and exome sequencing
Transcriptomics and epigenomics
Targeted and amplicon sequencing
Metagenomics and population-scale studies

2. MiSeq

Flexible, benchtop sequencing for targeted applications

The MiSeq is ideal for smaller-scale or targeted projects requiring fast turnaround and high accuracy. It supports:

Amplicon and small genome sequencing
Argeted resequencing
Whole transcriptome analysis
DNA methylation profiling
Microbial community analysis

Case Study: The MiSeq platform was used at CRID to characterize microbial populations in mosquitoes, revealing links to insecticide resistance.
Read the study: https://doi.org/10.1186/s12866-025-04114-0